Article By:
Rod Raynovich
Sunday, February 5, 2023 8:10 PM EDT
A few small cap biotechs lost momentum last week so now might be the time to take profits. But many of these stocks are favored because of their core technology and favored by funds; time to buy?
In this article: NTLA, IBB, PACB, XBI, SUPN, CRSP, ARKG, VCYT Also: CYRX, GERN, QDEL, HOLX, VRTX, EXAS, EVH, NVTA, TDOC
Don't Look Now, But Cathie Wood's Ark Is Taking On Water
$ARKG is just a sad story...